Claim: Christian Karsten Hansen held positions as senior scientist, co-founded Profound Pharma in Denmark and was involved in forming NB Capital.
Evidence: Hansen held positions as senior scientist and director of intellectual property management at Novo Nordisk 1992–1999, and was a member of Enzyme Research Management. He co-founded one of the early Danish biotechnology companies, Profound Pharma, in 1999, with Jan Møller Mikkelsen, and remained co-CEO thereof until its acquisition by Maxygen in 2000. In 2001, he co-founded the investment firm Nordic Biotech Advisors, subsequently renamed NB Capital. Created in Denmark in 1999 by Christian Karsten Hansen and Jan Møller Mikkelsen, formerly of Novo Nordisk, the company was funded by venture capital and a loan from Vækstfonden.